Clinical Trial Update: Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 clinical trials are exploring fluorescence imaging with Risankizumab-800CW in inflammatory bowel disease, including ulcerative colitis and C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Risankizumab-800CW (risankizumab-800CW)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Ulcerative Colitis (UC), Crohn Disease (CD) | Phase 1, Phase 2 | Status: RECRUITING